Bamlanivimab and Etesevimab administered in an outpatient setting for SARS-CoV-2 infection

Autor: DF Bavaro, L Diella, AG Solimando, S Cicco, E Buonamico, C Stasi, M Ciannarella, M Marrone, F Carpagnano, O Resta, GE Carpagnano, VO Palmieri, A Vacca, M Dell’Aera, A Dell’Erba, G Migliore, M Aricò, A Saracino

Publikováno v: Pathogens and global health. 116(5)

The early administration of anti-SARS-CoV-2 monoclonal antibodies (mAb) could decrease the risk of severe disease and the need of inpatients care. Herein, our clinical experience with Bamlanivimab/Etesevimab for the treatment of early SARS-CoV-2 infe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f512c102022097c7727a35f3428b44af
https://pubmed.ncbi.nlm.nih.gov/35138229

Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management.

Autor: Saltarella I; Section of Pharmacology, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy., Altamura C; Section of Pharmacology, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy., Solimando AG; Section of Internal Medicine and Clinical Oncology, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy., D'Amore S; Section of Internal Medicine and Clinical Oncology, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy., Ria R; Section of Internal Medicine and Clinical Oncology, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy., Vacca A; Section of Internal Medicine and Clinical Oncology, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy., Desaphy JF; Section of Pharmacology, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy., Frassanito MA; Section of Clinical Pathology, Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), University of Bari Aldo Moro, 70124 Bari, Italy.

Publikováno v: Cancers [Cancers (Basel)] 2024 Sep 18; Vol. 16 (18). Date of Electronic Publication: 2024 Sep 18.

Measurable therapeutic antibody in serum as potential predictive factor of response to anti-CD38 therapy in non-IgG-k myeloma patients.

Autor: Gigliotta E; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Plano F; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Corsale G; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Corsale AM; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Aquilina C; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Speciale M; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Rizzuto A; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Martino EA; Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy., Leotta D; Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy., Solimando AG; Unit of Internal Medicine 'Guido Baccelli', Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari 'Aldo Moro' Medical School, Bari, Italy., Ria R; Unit of Internal Medicine 'Guido Baccelli', Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari 'Aldo Moro' Medical School, Bari, Italy., Gentile M; Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy., Siragusa S; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Botta C; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy. Cirino.botta@unipa.it.

Publikováno v: Experimental hematology & oncology [Exp Hematol Oncol] 2024 Aug 06; Vol. 13 (1), pp. 82. Date of Electronic Publication: 2024 Aug 06.

Comprehensive analysis of clinical outcomes, infectious complications and microbiological data in newly diagnosed multiple myeloma patients: a retrospective observational study of 92 subjects.

Autor: Desantis V; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Section of Pharmacology, University of Bari 'Aldo Moro' Medical School, Bari, Italy. vanessa.desantis@uniba.it., Borrelli P; Department of Medical, Oral and Biotechnological Sciences, Laboratory of Biostatistics, University 'G. d'Annunzio' Chieti-Pescara, Chieti, Italy., Panebianco T; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Unit of Internal Medicine 'Guido Baccelli', University of Bari 'Aldo Moro' Medical School, Bari, Italy., Fusillo A; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Unit of Internal Medicine 'Guido Baccelli', University of Bari 'Aldo Moro' Medical School, Bari, Italy., Bochicchio D; Department of Medical, Oral and Biotechnological Sciences, Laboratory of Biostatistics, University 'G. d'Annunzio' Chieti-Pescara, Chieti, Italy., Solito A; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Unit of Internal Medicine 'Guido Baccelli', University of Bari 'Aldo Moro' Medical School, Bari, Italy., Pappagallo F; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Unit of Internal Medicine 'Guido Baccelli', University of Bari 'Aldo Moro' Medical School, Bari, Italy., Mascolo A; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Unit of Internal Medicine 'Guido Baccelli', University of Bari 'Aldo Moro' Medical School, Bari, Italy., Ancona A; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Unit of Internal Medicine 'Guido Baccelli', University of Bari 'Aldo Moro' Medical School, Bari, Italy., Cicco S; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Unit of Internal Medicine 'Guido Baccelli', University of Bari 'Aldo Moro' Medical School, Bari, Italy., Cerchione C; Department of Hematology, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Forlì-Cesena, Italy., Romano A; Department of Hematology, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Meldola, Forlì-Cesena, Italy.; Department of General Surgery and Medical-Surgical Specialties, Hematology Section, University of Catania, Catania, Italy., Montagnani M; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Section of Pharmacology, University of Bari 'Aldo Moro' Medical School, Bari, Italy., Ria R; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Unit of Internal Medicine 'Guido Baccelli', University of Bari 'Aldo Moro' Medical School, Bari, Italy., Vacca A; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Unit of Internal Medicine 'Guido Baccelli', University of Bari 'Aldo Moro' Medical School, Bari, Italy., Solimando AG; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), Unit of Internal Medicine 'Guido Baccelli', University of Bari 'Aldo Moro' Medical School, Bari, Italy. antonio.solimando@uniba.it.

Publikováno v: Clinical and experimental medicine [Clin Exp Med] 2024 Jun 27; Vol. 24 (1), pp. 137. Date of Electronic Publication: 2024 Jun 27.

Aggressive systemic mastocytosis with the co-occurrence of PRKG2::PDGFRB, KAT6A::NCOA2, and RXRA::NOTCH1 fusion transcripts and a heterozygous RUNX1 frameshift mutation.

Autor: Poscente M; UOSD Laboratorio di Genetica Medica, Ospedale Belcolle, Viterbo, Italy., Tolomeo D; Department of Biosciences, Biotechnology and Environment, University of Bari Aldo Moro, Bari, Italy., Arshadi A; Department of Biosciences, Biotechnology and Environment, University of Bari Aldo Moro, Bari, Italy., Agostini A; Department of Precision and Regenerative Medicine and Ionian Area, Unit of Internal Medicine and Clinical Oncology, University of Bari Aldo Moro, Bari, Italy., L'Abbate A; Istituto di Biomembrane, Bioenergetica e Biotecnologie Molecolari (IBIOM), Consiglio Nazionale delle Ricerche, Bari, Italy., Solimando AG; Department of Precision and Regenerative Medicine and Ionian Area, Unit of Internal Medicine and Clinical Oncology, University of Bari Aldo Moro, Bari, Italy; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Palumbo O; Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo Foggia, Italy., Carella M; Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo Foggia, Italy., Palumbo P; Division of Medical Genetics, Fondazione IRCCS-Casa Sollievo della Sofferenza, San Giovanni Rotondo Foggia, Italy., González T; Department of Medicine, Universidad de Salamanca, Department of Hematology, Hospital Universitario de Salamanca, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain., Hernández-Rivas JM; Department of Medicine, Universidad de Salamanca, Department of Hematology, Hospital Universitario de Salamanca, IBSAL, IBMCC-Centro de Investigación del Cáncer (USAL-CSIC), Salamanca, Spain., Bassi L; UOSD Laboratorio di Genetica Medica, Ospedale Belcolle, Viterbo, Italy., Isidori R; UOSD Laboratorio di Genetica Medica, Ospedale Belcolle, Viterbo, Italy., Dell'Aquila M; UOC Anatomia Patologica, Ospedale Belcolle, Viterbo, Italy., Trapè G; UOC Ematologia, Ospedale Belcolle, Viterbo, Italy., Latagliata R; UOC Ematologia, Ospedale Belcolle, Viterbo, Italy., Pessina G; UOSD Laboratorio di Genetica Medica, Ospedale Belcolle, Viterbo, Italy., Natoni F; UOSD Laboratorio di Genetica Medica, Ospedale Belcolle, Viterbo, Italy., Storlazzi CT; Department of Biosciences, Biotechnology and Environment, University of Bari Aldo Moro, Bari, Italy. Electronic address: cleliatiziana.storlazzi@uniba.it.

Publikováno v: Cancer genetics [Cancer Genet] 2024 Jun; Vol. 284-285, pp. 5-11. Date of Electronic Publication: 2024 Mar 07.